RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2009; 102(01): 173-175
DOI: 10.1160/TH09-02-0099
DOI: 10.1160/TH09-02-0099
Letters to the Editor
Tissue factor +5466A>G polymorphism predicts plasma TF levels in subjects with cryptogenic ischaemic stroke
Weitere Informationen
Publikationsverlauf
Received:
17. Februar 2009
Accepted after minor revision:
01. April 2009
Publikationsdatum:
24. November 2017 (online)
-
References
- 1 Steffel J, Lüscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113: 722-731.
- 2 Steppich B, Mattisek C, Sobczyk D. et al. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005; 93: 35-39.
- 3 Siegbahn A, Johnell M, Sorensen BB. et al. Regulation of chemotaxis by the cytoplasmic domain of tissue factor. Thromb Haemost 2005; 93: 27-34.
- 4 Butenas S, Undas A, Gissel MT. et al. Factor XIa and tissue factor activity in patients with coronary artery disease. Thromb Haemost 2008; 99: 142-149.
- 5 Ott I, Koch W, von Beckerath N. et al. Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis 2004; 177: 189-191.
- 6 Mälarstig A, Tenno T, Johnston N. et al. Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes. Arterioscler Thromb Vasc Biol 2005; 25: 2667-2672.
- 7 Undas A, Stepien E, Potaczek DP. et al. Tissue factor +5466A>G polymorphism determines thrombin formation following vascular injury and thrombinlowering effects of simvastatin in patients with ischemic heart disease. Atherosclerosis. 2008 e-pub ahead of print..
- 8 Austin H, Chimowitz MI, Hill HA. et al. Genetics and Stroke in the Young Study Group. Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke 2002; 33: 2762-2768.
- 9 Botto N, Spadoni I, Giusti S. et al. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale. Stroke 2007; 38: 2070-2073.
- 10 Offelli P, Zanchetta M, Pedon L. et al. Thrombophilia in young patients with cryptogenic stroke and patent foramen ovale (PFO). Thromb Haemost 2007; 98: 906-907.
- 11 Guercini F, Acciarresi M, Agnelli G. et al. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost 2008; 06: 549-554.
- 12 Terry CM, Kling SJ, Cheang KI. et al. Polymorphisms in the 5’-UTR of the tissue factor gene are associated with altered expression in human endothelial cells. J Thromb Haemost 2004; 02: 1351-1358.